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Background: The burdens of hypertension and diabetes are increasing in low- and middle-income countries
(LMICs). It is important to identify patients with these conditions early in the disease process. The goal of this study,
therefore, is to compare community- versus home-based screening for hypertension and diabetes in Kenya.
Methods: This was a feasibility study conducted by the Academic Model Providing Access to Healthcare (AMPATH)
program in Webuye, a town in western Kenya. Home-based (door-to-door) screening occurred in March 2010 and
community-based screening in November 2011. HIV counselors were trained to screen for diabetes and
hypertension in the home-based screening with local district hospital based staff conducting the community-based
screening. Participants >18 years old qualified for screening in both groups. Counselors referred all participants with
a systolic blood pressure (SBP) ≥160 mmHg and/or a random blood glucose ≥7 mmol/L (126 mg/dL) to a local
clinic for follow-up. Differences in likelihood of screening positive between the two strategies were compared using
Fischer’s Exact Test. Logistic regression models were used to identify factors associated with the likelihood of
following-up after a positive screening.
Results: There were 236 participants in home-based screening: 13 (6%) had a SBP ≥160 mmHg, and 54 (23%) had a
random glucose ≥ 7 mmol/L. There were 346 participants in community-based screening: 35 (10%) had a SBP
≥160 mmHg, and 27 (8%) had a random glucose ≥ 7 mmol/L. Participants in community-based screening were
twice as likely to screen positive for hypertension compared to home-based screening (OR=1.93, P=0.06). In
contrast, participants were 3.5 times more likely to screen positive for a random blood glucose ≥7 mmol/L with
home-based screening (OR=3.51, P<0.01). Rates for following-up at the clinic after a positive screen were low for
both groups with 31% of patients with an elevated SBP returning for confirmation in both the community-based
and home-based group (P=1.0). Follow-up after a random glucose was also low with 23% returning in the home-based
group and 22% in the community-based group (P=1.0).
Conclusion: Community- or home-based screening for diabetes and hypertension in LMICs is feasible. Due to low
rates of follow-up, screening efforts in rural settings should focus on linking cases to care.
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In Kenya, hypertension and diabetes mellitus are considered
widespread problems but there are few studies reporting
the prevalence of these diseases or replicable screening
strategies. An analysis of worldwide data in 2005 showed
that 639 million (625–654 million) patients with hyperten-
sion live in low and middle income countries (LMICs)
[1,2]. By 2025, the number of adults with hypertension is
predicted to increase by about 60% and almost three-
quarters of the world’s hypertensive population will live
in LMICs [3]. Studies have also found similar trends in
the prevalence of diabetes, with prevalence rates ranging
from < 1% in rural areas to > 20% in urban settings with
variation according to racial/ethnic group [4]. The Inter-
national Diabetes Federation estimates that the number of
individuals with diabetes in Africa will double to 23.9
million people by the year 2030 [5,6].
In Kenya, the available data on the burden of hyper-
tension or diabetes suggests prevalence rates of 12% and
6.6%, respectively [7]. However, low awareness of chronic
diseases, poverty, and health system factors, among other
issues, may lead to underestimates of the true prevalence
[8]. While worldwide rates of diabetes and hypertension
appear to be increasing, the paucity of locally relevant
data can hinder planning and developing preventative
and clinical care strategies to manage these diseases. As
such, strategies to improve the availability and accuracy
of local prevalence data are needed.
Whether home-based or community-based screening is
more appropriate in LMICs such as Kenya is unknown.
We therefore conducted a feasibility study to compare a
community-based versus home-based screening strategy
for hypertension and diabetes. To assess the feasibility
of these approaches, our primary aim was to obtain an
estimate of disease prevalence and describe the popula-
tions using both approaches. We also explored the pat-
tern of referral using various thresholds levels for blood
pressure and blood sugar measured during the screen-
ing exercise. We hope to use these comparative assess-
ments to inform local public health policy and health
system planning for future screening activities.
Methods
Study setting
This pilot study is an initiative of the Academic Model
Providing Access to Healthcare (AMPATH) program
located in western Kenya, which is a partnership between
Moi University, Moi Teaching and Referral Hospital and
a consortium of North American universities led by the
Indiana University School of Medicine. The history, orga-
nizational structure, and health programs of AMPATH
have been described elsewhere [9-11]. AMPATH has the
stated goal to build upon an academic foundation that
supports all 3 academic missions of service (throughhealthcare), teaching, and research. AMPATH delivers care,
provides education, and performs research in networks
of urban and rural Ministry of Health hospitals, health
centers, and dispensaries in western Kenya. AMPATH
has also developed considerable infrastructure for provid-
ing home-based and community-based counseling and
testing for HIV and has pioneered several innovative strat-
egies for integrating intensified case finding into its com-
prehensive prevention strategy [9,12]. AMPATH delivers
a comprehensive, community-based care program that
initially focused on patients infected with HIV but has
since expanded to provide maternal and child health
services and chronic disease management (specifically
diabetes and hypertension) to a catchment population
of over 2 million persons [2]. This specific feasibility test-
ing of screening for hypertension and diabetes was carried
out in the rural town of Webuye which is located within
the AMPATH catchment area. Webuye town (population
19,600 in 2011) was selected to carry out the pilot because
home-based counseling and testing (HBCT) for HIV was
underway at the time of the study [9,12]. There also exists
accessible infrastructure for long-term care of diabetes
and hypertension at Webuye District Hospital to manage
all the positively screened patients [13]. This project
was approved by the Institutional Research and Ethics
Committee based at Moi University School of Medicine.
Home-based screening
The home-based screening pilot was carried out in March
2010 alongside the ongoing HBCT for HIV. Five home-
based counselors (trained in HIV testing and counseling)
with at least a high school education who were contem-
poraneously providing home-based HIV screening under-
went a one-day training session on hypertension and
diabetes. This training highlighted the epidemiology, path-
ophysiology, risk factors, diagnosis/measurement and
screening methods for hypertension and diabetes. Coun-
selors were also instructed on the overall goals of treat-
ment and prevention options. Lastly, in practical sessions,
the counselors were taught about the appropriate meth-
odology for performing finger pricks, proper use of glu-
cose testing strips and meters (Abbott Optimum Xceed),
and proper use of an automatic sphygmomanometer
(OMRON HEM-712c) with a medium sized cuff (22 to
32 cm). Each counselor was instructed, observed and re-
quired to demonstrate proper diabetes and hypertension
screening techniques. After completion of the training
session, investigators (SP, SMA, COA, GSB) accompan-
ied counselors into at least one household to ensure
that they were able to provide appropriate counseling
and to measure blood pressure and blood sugar using
the proper technique.
All individuals 18 years of age and above who verbally
consented to have their blood pressure and sugar measured
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screening services using a standardized protocol. After
receiving verbal consent from the participants, counselors
counseled and tested participants for HIV. Participants
were also counseled on hypertension and diabetes screen-
ing and subsequently tested for random blood sugar (RBS).
Blood pressure was measured at the end of the home visit
after the counselor had tested for blood sugar and HIV.
Blood pressure was measured only once unless an error
message was recorded. In the case of an error message,
most participants had their blood pressure measured again.
If an error message was persistently observed, participants
were instructed to follow up at the specified confirmation
site at Webuye District Hospital.
Community-based screening
The community-based screening strategy was carried out in
November 2011 in conjunction with Webuye District Hos-
pital staff. Community mobilizers were used to sensitize the
community to the availability of a 2-day long diabetes and
hypertension screening program in the upcoming week to
commemorate World Diabetes Day. The availability of
this free screening was advertised through standard mo-
dalities of sensitization including discussion at church, via
community chiefs meetings (locally referred to as Barazas),
and by word of mouth via community leaders. Any person
18 years of age and above voluntarily visiting the screening
booth received a free blood pressure check, free blood
sugar test, had their height and weight recorded, and BMI
calculated. The screening booth was situated in the center
of town and was marked with signage and staff who
actively advertised for the screening. The screening booth
was easily visible and accessible to any participant inter-
ested in a free screening. Nurses and clinical staff with
experience in the management of chronic diseases at
the Webuye District Hospital chronic disease clinics were
responsible for performing all elements of the screening
program.
Screening and referral protocol
The same screening and referral protocol was used for both
the home-based and community-based screening strategies.
Age, sex, medical record number (if available), contact
information, HIV screening result (only performed in
home-based screening), blood pressure screening result,
and blood sugar screening result were recorded manually
for all participants by the counselors on a standardized
data collection sheet. In the community-based screening
event, screening staff also recorded the height and weight
on the same data collection sheet.
A cut-off systolic blood pressure (SBP) of ≥ 160 mmHg
was used in order to triage screened participants for
referral to the local clinic for diagnostic testing. This
cut-off was based on the limitation that only one bloodpressure reading was obtained during screening and to
avoid unnecessary referral due to one isolated high read-
ing and regression towards the mean. In addition, previ-
ous studies in sub-Saharan Africa have used a higher
screening threshold to avoid excess referral in settings
with resource constraints to maximize the use of resources
[14-18]. A diastolic blood pressure (DBP) cut-off was not
used to screen participants [19]. Participants who met
referral criteria were referred to the local clinic located
at Webuye District Hospital for follow-up blood pres-
sure measurements. At that follow-up visit, two blood
pressure measurements were taken during the same
visit. The average of the two blood pressures taken at
the clinic was calculated. Hypertension was diagnosed
based on the Joint National Committee VII criteria for
systolic or diastolic blood pressure (SBP ≥ 140 or DBP ≥
90 mmHg) [20].
A RBS cut-off of 7.0 mmol/L (126 mg/dL) was used as
the threshold for referring participants for confirmatory
testing in clinic. With the unpredictable nature of the
timing of the screening, it is possible that some partici-
pants would have been fasting at the time of screening.
Therefore, the recommended RBS cutoff of 11.1 mmol/L
(200 mg/dL) for diagnosing diabetes would not have
appropriately referred participants who arrived to the
screening with a fasting blood sugar result ≥ 7.0 mmol/L.
Because of this dynamic, the threshold for referral for
all participants was set at 7.0 mmol/L to ensure that any
patient who might meet either of these diagnostic criteria
would be offered confirmatory testing. Patients meeting
this referral threshold were then instructed to fast before
coming for confirmatory testing at the hospital based out-
patient diabetes clinic on a subsequent day. Patients with
a fasting blood sugar above 7.0 mmol/L in the clinic were
confirmed to have diabetes.
Participants with a positive screen for hypertension
(systolic blood pressure ≥ 160mmHg) or diabetes (RBS ≥
7 mmol/L) were provided an information sheet and refer-
ral card to follow up in clinic at the Webuye District
Hospital. The participants who returned to the hospital
based clinic were then provided with a free fasting blood
sugar testing and/or 2 separate resting blood pressure
readings to confirm the relevant diagnosis.
Participants found to have SBP 140–159 mmHg during
the initial screening were provided education on appropri-
ate lifestyle modifications and dietary strategies, such as salt
reduction. They were also instructed to obtain a follow-up
blood pressure reading within 6 months at any local blood
pressure testing facility. Participants with impaired fasting
glucose (5.6 – 6.9 mmol/L or 100 - 125 mg/dL) on the
clinic based confirmatory fasting blood glucose testing
were also instructed to engage in lifestyle modifications
and perform an annual fasting blood sugar at the nearest
available facility.
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betes or hypertension were instructed to engage in lifestyle
modifications and were registered into the appropriate
chronic disease clinic based on their diagnosis.
Participants who did not follow up after having a positive
screen for diabetes or hypertension in the initial screening
were contacted via phone and provided additional direc-
tions and encouragement to visit Webuye District Hospital
for confirmation. Participants were called on at least two
separate occasions at both the primary and alternate phone
number provided during the respective screening events.
Statistical analysis
All participants with complete data recorded in the screen-
ing register were included in this analysis. Descriptive
analyses were used to characterize the demographic char-
acteristics of the findings of the two different screening
strategies. To achieve the primary objective of comparing
the feasibility of both strategies, descriptive analyses were
used to assess the percentage of participants with an initial
positive screen for diabetes and elevated SBP in both
strategies. In addition, comparative statistical analyses
were performed to identify statistically significant differ-
ences between the two strategies for diabetes and hyper-
tension screening. The Fischer’s Exact Test was utilized
to compare the difference in the likelihood of screening
positive for diabetes or hypertension in the home-based
versus community-based screening strategy. Additionally,
the likelihood of following up after a positive screening
test was compared between the two screening strategies
and odds ratios (OR) for a positive screening were cal-
culated. Exact logistic regression was performed to
determine the characteristics associated with a positive
screening for either diabetes or hypertension. Linear
regression was utilized to identify the relationship of
relevant covariates with blood pressure and blood sugar.
In order to demonstrate the changes that might occur by
setting more aggressive referral thresholds, additional
analyses were completed to illustrate the additional
numbers of patients that might be referred using dif-
ferent screening criteria. All analyses were completed
using STATA® (College Station, Texas, Version 8).
Results
Overall findings
There were 236 participants in the home-based screening
and 346 participants in the community-based screening
who met the inclusion criteria for this analysis with partic-
ipants having a mean age of 37 (SD=15) and 39 (SD=13)
years, respectively (Figure 1). As seen in Table 1, the
home-based screening strategy identified 13 participants
(6% of the total population screened) with a SBP greater
than or equal to 160mmHg, while the community-based
strategy identified 35 participants (10% of the totalpopulation screened). Participants in the community-
based screening were almost twice as likely to have a
positive screening for hypertension compared to the home-
based screening arm (OR=1.93, Fischer’s exact test, P=0.06).
With regards to diabetes screening, 54 participants (23%)
and 27 participants (8%) in the home-based screening and
community-based screening, respectively, met the prede-
fined threshold requiring confirmatory blood sugar testing.
Participants in the home-based screening were 3.5 times
more likely to have a positive screening result than the
participants in the community-based screening (OR=3.51,
Fischer’s exact test, P<0.01).
Follow-up rates
The rate of follow-up for confirmatory testing in clinic
was low for both screening strategies. Of the 13 par-
ticipants in the home-based screening arm with a
SBP ≥160mmHg, 4 (31%) returned for confirmation. All
4 of these participants had a SBP ≥ 140mmHg when con-
firmatory testing was performed, thereby meeting cri-
teria for the confirmatory diagnosis of hypertension.
Similarly, in the community-based screening, 11 (31%) of
the 35 participants identified with an SBP ≥ 160mmHg
returned for confirmation and all of these participants
were confirmed to have a SBP ≥ 140 mmHg. There was
no difference in the odds of returning for confirmatory
follow up between the two groups (OR=0.97, Fischer’s
exact test, P=1.00).
In the analysis of blood sugar screening, 12 (23%) of
the 54 participants meeting the predefined criteria for
referral returned for the confirmatory fasting blood sugar
in the home-based screening with 3 receiving a confirmed
diagnosis of diabetes mellitus. In the community-based
arm, 6 (22%) of the 27 participants returned for the
confirmatory fasting blood sugar with only 2 partici-
pants being confirmatively diagnosed with diabetes. There
was no significant difference in the odds of returning for
confirmatory follow up between the two groups (OR=1.00,
Fischer’s exact test, P=1.00). With the limited number of
participants returning for the fasting blood confirmation
and the limited utility of a single random blood sugar,
secondary analysis did not reveal any meaningful results
beyond the low follow-up rate. None of the participants
in the home-based screening who had elevated blood
pressures or blood sugars tested positive for HIV. An
informal survey of the counselors at the end of home-
based screening revealed that participants who were
initially reluctant to undergo HIV testing were more
likely to be tested if they were offered screening for
diabetes or hypertension at the same time.
Alternate referral thresholds
If the threshold for referral during screening was set
to a SBP of ≥ 140 mmHg, an additional 29 participants
Initial eligibility screening
Confirmed disease
N= Number of participants RBS= Random blood sugar SBP= systolic blood pressure HC= Health center
Participants with SBP greater than or equal to 140 mmHg 
Participants with SBP greater than or equal to 160 mmHg
Participants with RBS greater than or equal to 7.0 mmolL
Home-based screening Community-based screening (health fair)
Phase 2: Confirmatory  
screening in health 
center








N=54 (23%)  
Confirmatory 
testing at HC 
N=6 (22%)  
N=2 (33%) 
confirmed 
diagnosis of DM 
Confirmatory 
testing at HC 
N=12  (23%) 
N=3 (25%) 
confirmed 
diagnosis of DM 
 
SBP 160mmHg 
N=13 (1%)  
Confirmatory 
testing at HC 








testing at HC 






Figure 1 Flow chart for screening results in home- and community-based screening.
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and community-based screening program, respectively,
would have been referred for confirmatory testing. Adding
a DBP cutoff of ≥ 90mmHg alongside SBP ≥ 140mHg as
a threshold for referral would have resulted in an add-
itional 4 participants in the community basing screening
and 16 in the home-based screening requiring referral. If a
DBP ≥ 100mmHg was included, 4 participants and 2 add-
itional participants in the home-based and community-
based screening, respectively, would have been referred
for confirmatory testing assuming that all participants
with a SBP ≥ 160mmHg would have already been referred.
In the combined analysis of the screening strategies,
there was a statistically significant higher likelihood of
screening positive for an elevated SBP if they screened
positive for an elevated RBS (P < 0.01). Likewise, there
was a statistically significantly higher likelihood of screen-
ing positive for an elevated RBS if they screened positive
for an elevated SBP (P < 0.01).
In the secondary analysis, univariate and multivariate
linear regression analysis revealed that participants of
older age were more likely to have a higher SBP (P < 0.01)
in the combined analysis of the home and community-
based screening with screen-positive participants having
a mean age of 52 compared to a mean age of 37 forscreen-negative participants. Other demographic char-
acteristics including gender and BMI (only evaluated in
community-based screening) did not have statistically
significant associations with SBP.
Discussion
Hypertension and diabetes mellitus are two increasingly
common conditions in LMICs that expose patients to
increased risk of mortality and morbidity [21]. Identify-
ing participants in the pre-clinical stages by screening
offers participants and providers an opportunity to mod-
ify long-term risk before serious complications occur
[22]. By performing both home-based and community-
based screening pilot studies for hypertension and diabetes
mellitus in western Kenya, we have gained important
insight into the burden of these conditions, challenges
in the long-term care of patients with these conditions
and the comparative advantages and disadvantages of
both strategies.
With a SBP screening referral cutpoint of 160 mmHg,
the home-based screening found 6% of the population
screened positive compared to 10% in the community-
based screening arm. While other studies have found
prevalence rates as high as 50% in Kenya, certain key
differences in methodology must be considered when
Table 1 Characteristics of the home-based and community-based screening program for diabetes and hypertension
Home-based screening Community-based screening
Number Screened 236 346
Age category (years)
18-24, n (%) 48 (20%) 49 (14%)
25-34 88 (37%) 99 (29%)
35-44 39 (17%) 85 (25%)
45-54 28 (12%) 69 (20%)
55-64 21 (9%) 32 (9%)
65-74 6 (3%) 12 (3%)
≥75 6 (3%) 0
Female, n (%) 146 (61%) 204 (59%)
SBP, mean (SD) mmHg 125 (19.28) 134 (21.35)
<120, n(%) 111 (47%) 85 (25%)
120 – 139 83 (35%) 157 (45%)
140 – 159 29 (12%) 69 (20%)
160- 179 10 (4%) 20 (6%)
180 – 199 2 (1%) 10 (3%)
≥200 1 (1%) 5 (1%)
DBP, mean (SD) mmHg 77 (13) 78 (11.34)
<60, n (%) 8 (3%) 15 (4%)
60 – 79 134 (57%) 203 (59%)
80 – 89 58 (25%) 74 (21%)
90 – 99 26 (11%) 40 (12%)
≥100 10 (4%) 14(4%)
RBS, mean (SD) mmol/L 6.1 (2) 5.0 (1.8)
<7.0, n (%) 182 (77%) 319 (92%)
7.0 - 9.9 48 (20%) 21 (6%)
10.0 - 12.9 4 (2%) 3 (1%)
≥ 13.0 2 (1%) 3 (1%)
Follow-up for Hypertension/Diabetes
Number of participants with elevated systolic blood pressures above
160 mmHg returning for confirmation
4 (31% of participants with an
elevated reading)
11 (31% of participants with an
elevated reading)
Number of participants with elevated systolic blood pressures above
160 mmHg returning for follow-up care
3 11
Number of participants with random blood sugars above 7 mmol/L
returning for confirmation
12 (23% of participants with an
elevated reading)
6 (22% of participants with an
elevated reading)
Number of participants with elevated blood sugars confirmed to have
diabetes and enrolled for follow-up care
3 2
Number of participants with both overt diabetes (RBS>9.9mmol/L) and
hypertension (SBP>160mmHg) on initial screening
3 2







SD=standard deviation, SBP=systolic blood pressure, DBP=diastolic blood pressure, RBS=random blood sugar, BP= blood pressure, SBP=systolic blood pressure,
BMI= body mass index, kg=kilograms, m=meters.
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blood pressure threshold was set and the population being
screened was predominantly rural with a distinct tribal
constituency largely made up of the Bukusu tribe. The low
prevalence of confirmed diabetes (1.2% in HBCT versus
0.6% in the community-based arm) must also be interpreted
cautiously when comparing the findings to other studies
as this study utilized a more contextualized screening
strategy designed to fit within AMPATH’s overarching
screening approach while not necessarily following all the
standard diagnostic criteria typically utizlized in resource-
rich settings. A consistent finding between the two strat-
egies was the low rate of follow-up amongst patients who
met the screening threshold. Despite the inclusion of a
system for phone-based reminders for all participants
with elevated results, the follow-up rate for confirma-
tory testing was low and many participants were un-
available via the phone number provided or unwilling to
come in to the referral hospital. This lack of follow-up
illustrates a major deficiency in the feasibility of a one-
time screening approach amongst rural patient popula-
tions without an intensive linkage strategy to ensure
patients enroll into a care program. Patient education
and limited awareness of the need for testing, cost of
travel or other factors may also have been responsible
for the low follow-up rate despite the provision of edu-
cation by community health workers and relatively close
proximity of the health facility to patients screened (90%
of screened patients lived within 2 miles of the facility).
This investigation also highlights the need for confirma-
tory screening strategies that can be completed in one
encounter in either the home- or community-based set-
ting. For example, as additional data emerges for the
role of glycosylated hemoglobin (A1c) in diagnosing dia-
betes in African populations, this testing strategy can
be utilized to provide point-of-care confirmation in one
encounter with or without prior screening. Currently,
this approach is largely limited by the excessive costs of
this form of testing, limited data on the reliability of
A1c in sub-Saharan African populations, and the re-
source constraints which pervade this setting. With the
limited interpretation which can come from a single
RBS and difficulty in obtaining a fasting blood sugar in
a voluntary impromptu screening, there is considerable
need for more contextualized strategies [23]. As access
to point of care A1c testing is expanded in resource-
constrained settings, it is hoped that questions about its
accuracy in these populations can be addressed and
subsequently be integrated into home-based screening
and care to continue to improve the ease with which
patients can be screened to confirm diabetes [24,25].
The study utilized a voluntary, convenience sampling
approach to screen a broad range of patients regardless
of their baseline risks for diabetes or hypertension. Theinclusive nature of this screening program and low follow-
up rates for confirmatory testing are largely responsible
for the relatively low prevalence rates observed during
this screening activity. Patients voluntarily submitting
to screening in the community-based arm were more
likely to screen positive for elevated SBP than in the
home-based arm. Because of the voluntary nature of
this screening, it is possible that patients with a higher
risk or family history of hypertension were more likely
to submit to screening than in the home-based arm
which screened all eligible patients in the homes visited.
Based on these findings, more targeted screenings assessing
high-risk populations will be conducted to focus on the
delivery of care to patients more likely to have hyperten-
sion. Conversely, a higher percentage of patients met the
positive screening threshold for diabetes in the home-
based arm than in the community-based arm. One poten-
tial explanation for this is that many participants were
screened shortly after having their morning or afternoon
tea. It is possible the timing of the consumption of sugar
containing tea and the completion of a random blood
glucose screening could have led to a small increase in
their blood glucose measurement above 7.0 mmol/L as
20% of the patients in the home-based arm compared to
6% in the community-based arm had a RBS in the 7.0 –
9.9 mmol/L range. Because of the low rates of follow-up,
it is unclear whether these mildly elevated random blood
glucoses represent true cases of diabetes or false positive
screenings.
Since completing this investigation, AMPATH has
partnered with the Kenyan Ministry of Health to begin
wide scale implementation of a diabetes and hyperten-
sion screening program. To mitigate against low rates of
follow-up, a linkage strategy including the provision of
home-based care via community health workers has been
incorporated. This integrated approach utilizing govern-
mental partnership has been a vital component to ad-
dressing the large healthcare workforce needs for chronic
disease management. As demonstrated in this study,
setting a cut point of referral for participants with a SBP
of greater than 160 mmHg results in a smaller number
of people who will be referred for confirmation compared
to lower SBP thresholds. In addition, we did not include a
DBP cut-off yet found many participants with single DBP
measurements greater than or equal to 90mmHg. Whether
lower thresholds would have resulted in a higher or lower
true positive rate is unknown given the low numbers of
participants who returned for follow-up and that those
with lower SBPs or elevated DBP were not referred for
testing. However, with the availability of a larger pool of
healthcare workers through partnership with the Ministry
of Health, participants are now being referred if they have
a SBP ≥ 140mmHg or DBP ≥ 90mmHg in order to ensure
that confirmatory testing is offered to the greatest number
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diabetes and lack of follow up after elevated RBS, it is diffi-
cult to utilize this feasibility assessment to refine the cutoff
values for diabetes referral. To better understand the opti-
mal cutoff values, we are currently employing a revised
strategy in which patients are scheduled to have con-
firmatory testing for fasting blood sugar via home-based
testing or at a local public health facility that is within
close proximity to their residence.
While the primary goal of this study was to demon-
strate feasibility through practical implementation, there
are several key limitations associated with this approach.
Because of the logistical challenges in implementing the
different screening programs, there was a considerable delay
in the time frames that both strategies were implemented.
Because of this limitation, it is possible that there was
some overlap in the patients participating in both screen-
ing activities. The potential also exists for an increase in
the awareness and prevalence of chronic diseases during
the time between the two screening strategies which could
confound the comparison of the strategies.
One of the challenges in implementing a contextualized
program for this pilot was setting appropriate thresholds
for referral for diabetes and hypertension. Because of the
convenience sampling approach, we were only able to
perform a single screening BP and random blood screen-
ing. While neither approach represents the recommended
diagnostic approach in isolation, it represents the most
practical screening approach given the limitations of the
rural setting in which this pilot was conducted. Through
the anecdotal feedback from the screening counselors,
intermittent error readings were found when performing
blood pressure measurements. However, after performing
repeat tests, they were able to obtain blood pressure read-
ings on all the participants at the time of the home-based
or community based screening. As we continue to expand
the chronic disease management program to additional
areas we hope to continue to revise our referral thresholds
and screening approaches to ensure we maximize the
long-term health care benefits for the populations we serve
within the limited resources available. In addition, the
potential impact of offering screening for hypertension
or diabetes alongside HIV testing on acceptability of
HIV testing needs to be explored further. Despite the
challenges, we were able to assess the different screening
strategies and identify the primary barriers with each strat-
egy. This activity has greatly assisted our ongoing efforts to
build sustainable chronic disease infrastructure throughout
our western Kenyan catchment area.
With the logistical challenges of providing laboratory-
based diagnosis of diabetes using venous blood samples,
this study relied on the less preferred diagnostic strategy
based on point-of-care glucose meters. While these have
not been formally approved for diagnosis, they have beensuggested as a suitable alternate testing strategy in set-
tings where laboratory based diagnosis is not readily
available [26].
Conclusions
This study illustrates that home- and community-based
screening for hypertension and diabetes can be carried
out in Kenya’s rural areas. This investigation also illus-
trates the feasibility of screening for chronic diseases
alongside the infrastructure that has been built to address
the multifactorial aspects of HIV management and pre-
vention. Both screening strategies identified a large pool
of high-risk participants which had similar rates of poor
follow-up after screening. When screening for hyperten-
sion is assessed in isolation from the other aspects of the
healthcare system, the community-based screening strat-
egy seems to attract higher risk participants compared to
a more comprehensive home-based screening strategy. One
of the major benefits of home-based screening, not specific-
ally discussed in this study, is the potential for greater link-
age to the healthcare system to facilitate home-based care
in the future.
Based on the observations in this investigation the de-
cision to utilize a community-based versus home-based
should largely be based on the overarching capacity of
the healthcare system in which it is being implemented.
For settings where considerable infrastructure exists for
more portable, home-based care and diagnosis, the home-
based screening strategy provides many potential advan-
tages in the long-term management of patients beyond
screening. For example, within AMPATH, smartphones
are now used to capture the GPS coordinates of citizens
within our catchment area for subsequent registration and
follow-up from community healthcare workers [12]. For
settings where care is largely centralized at healthcare
facilities, community-based screening provides a quick
and easy to implement approach with a potentially higher
yield of high risk patients.
However, to increase the long-term health benefits for
the rural populations these efforts are intended to serve,
an integrated approach linking screening, care and follow-
up regardless of the point of service delivery needs to be
implemented to reduce the preventable complications of
hypertension and diabetes.
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